Related Experiment Video
Updated: May 14, 2026
10:33
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Liposomes for brain delivery
Francesco Lai1, Anna Maria Fadda, Chiara Sinico
1University of Cagliari, Dipartimento di Scienze della Vita e dell'Ambiente, Via Ospedale 72, 09124 Cagliari, Italy.
Expert Opinion on Drug Delivery
|February 5, 2013
Summary
Liposomes offer promising strategies for brain-targeted drug delivery by overcoming the blood-brain barrier (BBB). Tailoring liposome design with specific ligands and transport mechanisms is crucial for effective brain uptake of therapeutics.
Area of Science:
- Pharmaceutical Sciences
- Neuroscience
- Biotechnology
Background:
- The blood-brain barrier (BBB) presents a significant challenge for brain drug delivery, limiting therapeutic agent uptake.
- Liposomes are increasingly recognized as effective carriers for brain-targeted drug delivery due to their drug-carrying capacity and surface modification potential.
Purpose of the Study:
- To review various strategies utilizing liposomes for transporting therapeutics and imaging agents across the BBB.
- To explore the anatomy of the BBB and its physiological transport mechanisms relevant to drug permeation.
Main Methods:
- Detailed review of liposome-based strategies for brain delivery.
- Analysis of BBB anatomy and physiological transport mechanisms.
- Examination of liposome surface modification with ligands for targeted delivery.
Main Results:
- Significant advancements in ligand-conjugated liposomal systems for brain delivery have been achieved.
- Liposomes can be engineered to incorporate substantial drug loads and decorated with targeting ligands.
Conclusions:
- No single liposomal formulation is universally effective for brain targeting.
- Optimal liposome design requires careful selection of homing devices and transport mechanisms tailored to specific therapeutic needs.
